BridgeBio says oral drug to treat rare heart disease meets trial goal
HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.
HQ Team May 10, 2023: Forest ecosystems are a trading ground for individual trees and fungi, each trying to make the best deal.
HQ Team April 19, 2023: Swedish researchers have redesigned human antibodies to signal the immune system to fight the COVID-19 virus and open.
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar.
A recall of Swedish makers' of heart devices has been classified by the FDA as "most serious" since they could lead to severe.
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
Seagrass can reduce cliff erosion by up to 70% due to its root mats binding the sand, a study found.